A recent dispute in Belagavi has shed light on the dangers of disease-specific sub-limits in health policies, urging consumers to scrutinise renewal documents carefully to avoid unexpected claim reductions.
A consumer dispute in Belagavi has put the spotlight back on a common but often overlooked feature of health insurance: hidden limits that can sharply reduce a payout even when the sum insured appears generous. In the case reported by Business Standard, Devdutt Kopikar had held a health policy since 2019 and later increased cover from ₹3 lakh to ₹5 lakh. After he suffered a stroke in March 2025, his family claimed ₹4,28,308, but the insurer paid only ₹2 lakh, pointing to a disease-specific sub-limit. The commission found the insurer had not clearly proved that the cap formed part of the contract, had not shown that the restrictive term was properly communicated, and could not establish that older terms continued after renewal. It ordered the company to pay the outstanding amount, plus interest, compensation and litigation costs.
The ruling matters because disease-wise caps are a familiar feature in many health plans and can appear in several forms. Guides from Ditto, Policyjack, Pazcare and Findecode explain that sub-limits may apply to named illnesses, procedures such as cataract or joint replacement surgery, room rent, maternity care, modern treatments and even consumables. These caps can be fixed in rupees or linked to a percentage of the total cover, meaning a policy with a large overall sum insured may still leave a patient with a substantial bill once the insurer applies a treatment-specific ceiling.
The wider regulatory backdrop is also important. Under Insurance Regulatory and Development Authority of India rules, health policies are generally meant to be renewable for life, and insurers are not supposed to worsen terms to the policyholder’s disadvantage at renewal. Business Standard reports that specialists say operational changes, such as a different network hospital list or claims administrator, may occur, but they should not cut back the protection already bought. The Belagavi decision reinforces that an insurer seeking to rely on a restriction must be able to show that the limitation genuinely formed part of the renewed contract.
That is why policyholders are being urged to read the paperwork carefully every year. The documents to compare include the expiring and renewed policy schedules, the full wording, endorsements, the Customer Information Sheet, the renewal notice and any proposal forms. The article also notes that the Customer Information Sheet is supposed to summarise key benefits and limits in plain language; in the Belagavi dispute, the sub-limit later cited by the insurer did not appear there, which weighed against the company. Consumers are also advised to check for room-rent caps, co-payment clauses, waiting periods, exclusions and any unexplained premium rise.
The article further warns that a higher sum insured is not automatically granted just because a policyholder pays a larger premium. When cover is enhanced, the insurer may underwrite the additional portion afresh, and the policyholder must disclose any material health changes, including diagnoses, treatment, medication and ongoing tests. If the extra cover is approved, it should be confirmed in writing and reflected in the schedule. If a claim is disputed, policyholders should ask the insurer to identify the restriction it relied on and to produce the documents showing how the term was communicated. Business Standard says unresolved complaints can be escalated through the insurer, Irdai’s grievance system, the Insurance Ombudsman and, where appropriate, the consumer courts.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
